Literature DB >> 372221

Simplified chromatographic separation of immunoglobulin M from G and its application to toxoplasma indirect immunofluorescence.

N Pyndiah, U Krech, P Price, J Wilhelm.   

Abstract

The indirect immunofluorescent (IIF) antibody technique for the detection of Toxoplasma gondii immunoglobulin M (IgM) often gives false negative results, probably due to the competition between IgG and IgM. We therefore adapted a gel filtration procedure for the separation of IgG and IgM to a routine diagnostic test capable handling at least 10 sera per day and requiring only 50 microliters of serum. The results from 108 sera having positive complement fixation titers for Toxoplasma showed that 17 were IgM positive when the whole serum was tested by IIF compared with 55 positive when the IgM fraction was used. Sera with antideoxyribonucleic acid titers do not give false positive results after fractionation, and the removal of IgG eliminates false positive results due to rheumatoid factor. A prospective study showed that Toxoplasma IgM may persist up to 9 months.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 372221      PMCID: PMC272984          DOI: 10.1128/jcm.9.2.170-174.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Modified staphylococcal absorption method used for detecting rubella-specific immunoglobin M antibodies during a rubella epidemic.

Authors:  R Handsher; A Fogel
Journal:  J Clin Microbiol       Date:  1977-06       Impact factor: 5.948

2.  The binding of murine IgM to Staphylococcal A protein.

Authors:  M R MacKenzie; G A Gutman; N L Warner
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

3.  Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies.

Authors:  T Vesikari; A Vaheri
Journal:  Br Med J       Date:  1968-01-27

4.  Serum IgM and IgG responses in postnatally acquired rubella.

Authors:  J M Best; J E Banatvala; D Watson
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

5.  A simple, inexpensive gel filtration technique for use in diagnostic serology.

Authors:  J R Pattison; J E Mace
Journal:  J Clin Pathol       Date:  1973-04       Impact factor: 3.411

6.  A rapid immunofluorescent procedure for the detection of specific IgG and IgM antibody in sera using Staphylococcus aureus and latex-IgG as absorbents.

Authors:  S Chantler; E Devries; P R Allen; B A Hurn
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

7.  19S and 7S anti-toxoplasma antibodies in diagnosis of acute congenital and acquired toxoplasmosis.

Authors:  J S Remington; M J Miller
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

8.  False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies.

Authors:  F G Araujo; E V Barnett; L O Gentry; J S Remington
Journal:  Appl Microbiol       Date:  1971-09

9.  The use of indirect immunofluorescence to evaluate the gel filtration method of fractionating human immunoglobulins.

Authors:  R Hannon; M Haire; G B Wisdom; D W Neill
Journal:  J Immunol Methods       Date:  1975       Impact factor: 2.303

10.  Separation of rubella IgM, IgA, and IgG antibodies by gel filtration on agarose.

Authors:  A Bürgin-Wolff; R Hernandez; M Just
Journal:  Lancet       Date:  1971-12-11       Impact factor: 79.321

View more
  22 in total

1.  Detection of specific IgG and IgM antibodies to Toxoplasma gondii with a commercially available enzyme immunoassay kit system.

Authors:  A H Balfour; J P Harford
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

2.  Membrane filtration enzyme immunoassay, a novel, rapid method for measurement of virus-specific immunoglobulins G and M and detection of viral antigens.

Authors:  G R Barnett; G A Tannock; D A Bryce
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

3.  Interlaboratory evaluation of indirect enzyme-linked immunosorbent assay, antibody capture enzyme-linked immunosorbent assay, and immunoblotting for detection of immunoglobulin M antibodies to Toxoplasma gondii.

Authors:  P Herbrink; A M van Loon; J P Rotmans; F van Knapen; W C van Dijk
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

4.  Enzyme-linked immunosorbent assay that uses labeled antigen for detection of immunoglobulin M and A antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double-sandwich enzyme-linked immunosorbent assay.

Authors:  A M van Loon; J T van der Logt; F W Heessen; J van der Veen
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

5.  Serodiagnosis of viral hepatitis A: rise in antibody titre and evaluation of three methods for detecting early and late antibodies.

Authors:  C Girardet; R Peitrequin; P C Frei
Journal:  Experientia       Date:  1983-08-15

6.  Evaluation of an enzyme-linked immunosorbent assay specific for human immunoglobulin G as a Screening test for detecting anti-toxoplasma antibodies.

Authors:  B C Woodward
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

7.  Enzyme-linked immunosorbent assay for detection of immunoglobulin M antibodies against Toxoplasma gondii.

Authors:  W Duermeyer; F Wielaard; H van Gruijthuijsen; J Swinkels
Journal:  J Clin Microbiol       Date:  1980-12       Impact factor: 5.948

8.  Absence of circulating HBsAg in acute hepatitis B.

Authors:  J Fasel-Felley; R Peitrequin; P C Frei
Journal:  Infection       Date:  1984 May-Jun       Impact factor: 3.553

9.  Diagnosis of acute toxoplasmosis by an enzyme immunoassay for specific immunoglobulin m antibodies.

Authors:  F Wielaard; H van Gruijthuijsen; W Duermeyer; A W Joss; L Skinner; H Williams; E H van Elven
Journal:  J Clin Microbiol       Date:  1983-06       Impact factor: 5.948

10.  Direct micromethod for diagnosis of acute and congenital Chagas' disease.

Authors:  H Feilij; L Muller; S M Gonzalez Cappa
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.